HomeInsightsStock Comparison

Medicamen Biotech Ltd vs Vilin Bio Med Ltd Stock Comparison

Medicamen Biotech Ltd vs Vilin Bio Med Ltd Stock Comparison

Last Updated on: Jun 21, 2025

Key Highlights

  • The Latest Trading Price of Medicamen Biotech Ltd is ₹ 403.45 as of 20 Jun 15:30.
  • The P/E Ratio of Medicamen Biotech Ltd changed from 16.6 on March 2020 to 44.5 on March 2024 . This represents a CAGR of 21.80% over 5 yearsThe P/E Ratio of Vilin Bio Med Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Medicamen Biotech Ltd changed from ₹ 220.75 crore on March 2020 to ₹ 487.1 crore on March 2024 . This represents a CAGR of 17.15% over 5 yearsThe Market Cap of Vilin Bio Med Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Medicamen Biotech Ltd for the Mar '25 is ₹ 34.84 crore as compare to the Dec '24 revenue of ₹ 45.28 crore. This represent the decline of -23.06% The revenue of Vilin Bio Med Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Medicamen Biotech Ltd for the Mar '25 is ₹ 3.62 crore as compare to the Dec '24 ebitda of ₹ 6.85 crore. This represent the decline of -47.15% The ebitda of Vilin Bio Med Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Medicamen Biotech Ltd changed from ₹ 3.95 crore to ₹ 1.86 crore over 8 quarters. This represents a CAGR of -31.38% The net profit of Vilin Bio Med Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Medicamen Biotech Ltd changed from 4.98 % on March 2020 to 9.56 % on March 2024 . This represents a CAGR of 13.93% over 5 yearsThe Dividend Payout of Vilin Bio Med Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Medicamen Biotech Ltd

  • A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
  • The Company has presence in 40+ countries.
  • Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
  • MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
  • The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

About Vilin Bio Med Ltd

  • Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
  • The Company started its first commercial production in year 2006.
  • In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
  • In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014.
  • The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023 to the Public. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand.

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech rallies after securing USFDA approval for Bortezomib injection

The ANDA pertains to Bortezomib for Injection, 3.5 mg single-dose vial. The USFDA has dete...

Read more

03 Jun 2025 13:07

News

Board of Medicamen Biotech recommends final dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

31 May 2025 12:29

News

Medicamen Biotech to hold board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

23 May 2025 20:27

News

Medicamen Biotech to convene EGM

Medicamen Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company wi...

Read more

27 Feb 2025 16:47

News

Medicamen Biotech announces board meeting date

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 26 Febru...

Read more

21 Feb 2025 19:50

News

Medicamen Biotech to declare Quarterly Results

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 11 Febru...

Read more

05 Feb 2025 14:45

Vilin Bio Med Ltd News Hub

News

Vilin Bio Med to conduct board meeting

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 17 May 2025....

Read more

12 May 2025 10:32

News

Vilin Bio Med announces board meeting date

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 10 January 2...

Read more

06 Jan 2025 12:56

News

Vilin Bio Med to hold AGM

Vilin Bio Med announced that the 18th Annual General Meeting (AGM) of the company will be ...

Read more

14 Sep 2024 10:29

News

Vilin Bio Med announces board meeting date

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 22 August 20...

Read more

17 Aug 2024 10:21

News

Vilin Bio Med to table results

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 29 May 2024 ...

Read more

24 May 2024 13:45

News

Vilin Bio Med to discuss results

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 8 February 2...

Read more

03 Feb 2024 13:01

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Vilin Bio Med Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Medicamen Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vilin Bio Med Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Medicamen Biotech Ltd and Vilin Bio Med Ltd

Which company has a larger market capitalization, Medicamen Biotech Ltd or Vilin Bio Med Ltd?

Market cap of Medicamen Biotech Ltd is 547 Cr while Market cap of Vilin Bio Med Ltd is 39 Cr

What are the key factors driving the stock performance of Medicamen Biotech Ltd and Vilin Bio Med Ltd?

The stock performance of Medicamen Biotech Ltd and Vilin Bio Med Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Biotech Ltd and Vilin Bio Med Ltd?

As of June 21, 2025, the Medicamen Biotech Ltd stock price is INR ₹403.45. On the other hand, Vilin Bio Med Ltd stock price is INR ₹28.4.

How do dividend payouts of Medicamen Biotech Ltd and Vilin Bio Med Ltd compare?

To compare the dividend payouts of Medicamen Biotech Ltd and Vilin Bio Med Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions